Data Byte: at $1.9B valuation, Atea leads this week’s IPOs 

Atea led the pack of IPOs priced in the final week before the U.S. election, trading up 26% to $30.34 on its first day of trading Friday after raising $300 million. The upsized offering valued Jean-Pierre Sommadossi’s antiviral company at $1.9 billion; it closed the day at a market cap of $2.4 billion. 

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) sold 12.5 million shares at $24 per share in the offering a week after out-licensing ex-U.S. rights to its COVID-19 therapy AT-527 to Roche (SIX:ROG; OTCQX:RHHBY) in a deal that brought in $350 million up front ...